{
    "2021-05-17": [
        [
            {
                "time": "",
                "original_text": "金域医学(603882.SH)两名董监高拟合计减持不超5.13万股 拟减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "董监高",
                        "减持",
                        "5.13万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "注意！金域医学：于世辉、汪令来拟减持不超过约5.12万股 拟减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "于世辉",
                        "汪令来",
                        "减持",
                        "5.12万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学：两股东拟合计减持不超0.0111%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "股东",
                        "减持",
                        "0.0111%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)：2名董监高拟减持合计不超5.125万股 拟减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "董监高",
                        "减持",
                        "5.125万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【国君金工】核心指数成分股调整名单及冲击成本预测",
                "features": {
                    "keywords": [
                        "国君金工",
                        "核心指数",
                        "成分股调整",
                        "冲击成本预测"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "指数"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年年报及2021年一季报业绩综述：业绩持续回暖 行业景气度高",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报",
                        "一季报",
                        "业绩回暖",
                        "景气度高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药周报：业绩空窗期 建议重点关注高壁垒好赛道估值合理个股",
                "features": {
                    "keywords": [
                        "医药周报",
                        "业绩空窗期",
                        "高壁垒",
                        "估值合理"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}